---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-013399"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T08:31:34.076050+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech regains Nasdaq minimum bid price compliance; delisting risk removed

## Summary
- Received Nasdaq letter confirming compliance with minimum bid price of $1.00/share after 10 consecutive business days.
- Previously received deficiency notice on June 22, 2023 with compliance deadline of December 19, 2023.
- Common shares (EDSA) now meet Nasdaq Capital Market listing requirement; matter closed.

## SEC filing metadata
- accession: 0001654954-23-013399
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000165495423013399/0001654954-23-013399-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000165495423013399/edsa_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-013399
- JSON: https://secwatch.observer/filing/0001654954-23-013399.json
- Plain text: https://secwatch.observer/filing/0001654954-23-013399.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.